Dermapen

Dermapen is the world's original and leading automated micro-needling device, designed to promote skin rejuvenation and healing. The brand pioneered the automated vertical needle technology that has become the industry standard for fractional skin rejuvenation, addressing concerns such as aging, scarring, and pigmentation.

Originally founded in Australia, the brand is owned by DermapenWorld, a global clinical technology provider. The company maintains strict quality controls and produces its high-end devices and specialized skincare line (Dp Dermaceuticals) to medical-grade standards. The technology is patented and widely recognized in both dermatological and aesthetic clinics worldwide.

From its Australian roots, Dermapen has expanded its reach through a sophisticated distribution network, ensuring that the brand remains at the forefront of the aesthetic industry. As of 2026, the brand continues to be owned by its founding entity, DermapenWorld, headquartered in Sydney, Australia.